Dry Eye Syndrome Market Growth Drivers and Challenges:
Growth Drivers
- Rising Prevalence of Dry Eye Syndrome- The various environmental problems have led to a rising problem of dry eyes among the population. Higher number of people are getting affected by less secretion tears and irritation in their eyes. Globally, around 5 to 50% of the population suffers from dry eye disease.
- Higher Use of Eye Drops- Eye drops are used by the patients suffering from dry eye symptoms, that provides relief to the eyes through adding moisture and nutrition in the eyes. Hence, it is projected to drive the growth of the global dry eye syndrome market. In the United Kingdom, around 3 million people or more used eye drops and ointments per day in 2020. Moreover, there are approximately 2 million people who used eye drops and ointments less frequently than once per month came after this.
- Surging Count of People Using Contact Lenses- The post lens tear films become thin, when there is a lack of tear volume in the eye, and the friction between the corneal surface and the contact lens rises, that is expected to increase the market’s growth. The part of 45 million of adult population in the United States wears contact lenses and nearly two-third share of this population is female.
- Growing Number of Elderly Population- In 2020, the count of the geriatric population of the age 60 years and above rose form 1 billion to around 1.4 billion, as per the statistics of the World Health Organization.
- Increased Popularity of Laser Treatments- The dry eye symptoms increase after the few months of surgery owing to the lack of moisture in the eyes, for which eye drops are recommended by the doctors. Therefore, it is predicted to rise the growth of the global dry eye syndromes market over the forecast period. Every year, 30 million people have laser eye surgery. Every year around 100,000 individuals in the United Kingdom go for laser eye surgery, moreover, nearly 10 million people in the United States had laser eye surgery in 2018.
Challenges
- Lack of Awareness about the Dry Eye Syndrome - The general public has little knowledge regarding eye health. Many dry eye symptoms that can be treated or alleviated quickly with a proper diagnosis and drugs are not well understood. People rarely go to the ophthalmologist unless there is a serious problem and it is certainly impeding the market growth.
- Lack of Effective Health Insurance Programs Across Several Nations
- Higher Cost of the Treatment
Dry Eye Syndrome Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
6.1% |
|
Base Year Market Size (2025) |
USD 6.4 billion |
|
Forecast Year Market Size (2035) |
USD 11.57 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of dry eye syndrome is evaluated at USD 6.75 billion.
The global dry eye syndrome market size was worth around USD 6.4 billion in 2025 and is set to register a CAGR of around 6.1%, exceeding USD 11.57 billion revenue by 2035.
North America dry eye syndrome market will secure around 40.8% share by 2035, driven by a high number of dry eye sufferers and increasing use of eye drops.
Key players in the market include Lumenis Be Ltd., Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd.